Blood pressure and lipid profile are important determinants of cardiovascular risk in patients
with type 2 diabetes mellitus (T2DM). To identify the pleiotropic effects of vildagliptin other …

Background and aims This study aimed to assess the effects of vildagliptin on the prevention
of cardiovascular diseases in Thai patients with type 2 diabetes mellitus using the Thai …

Introduction We have previously shown modest weight loss with vildagliptin treatment. Since
body weight balance is associated with changes in blood pressure (BP) and fasting lipids …

Aims: To assess the long‐term safety and the sustained glycaemic control of vildagliptin
compared with rosiglitazone over 2‐year treatment in drug‐naïve type 2 diabetes mellitus …

Background To assess the efficacy of a vildagliptin and metformin combination therapy to a
metformin monotherapy in type 2 diabetes mellitus patients. Methods: Sixty-one patients with …

Abstract This 24-week double-blind, randomized, multicenter, placebo-controlled, parallel-
group study was performed in 632 drug-naïve patients with type 2 diabetes to assess …

The aim of the present study was to assess the efficacy and safety of vildagliptin plus
metformin combination therapy in patients with type II diabetes mellitus. Type II diabetic …

The aim of this study was to assess the efficacy of a combination therapy of vildagliptin plus
an α-glucosidase inhibitor for patients with type II diabetes mellitus. Type II diabetic patients …

Aim: This study was conducted to assess efficacy and tolerability of vildagliptin in drug‐naïve
patients with type 2 diabetes and mild hyperglycaemia. Methods: Multicentre, double‐blind …

The aim of the study was to compare the effects of vildagliptin added to pioglitazone or
glimepiride on metabolic and insulin resistance related-indices in poorly controlled type 2 …